Market closedNon-fractional

CorMedix/CRMD

13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX

About CorMedix

Cormedix Inc is a biopharmaceutical company focused on developing and commercializing therapeutic products for the prevention and treatment of infectious and inflammatory diseases. The Company's focus is on the commercialization of its product, DefenCath, in the United States (U.S.) and other key markets.

Ticker

CRMD

Sector

Healthcare

Trading on

NASDAQ

Industry

Pharmaceuticals

Headquarters

Berkeley Heights, United States

Employees

83

CorMedix Metrics

BasicAdvanced
$227M
Market cap
-
P/E ratio
-$0.93
EPS
1.79
Beta
-
Dividend rate
$227M
1.79
6.651
6.141
0.822
1.088
-1,238.24%
-53.68%
-89.76%
3.91
4.05
-4.903
15.76%
6.76%

What the Analysts think about CorMedix

Analyst Ratings

Majority rating from 4 analysts.
Buy

CorMedix Financial Performance

Income StatementBalance sheetCash Flow

Income Statement

Revenues and expenses
0.00% profit margin
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$0
NaN%
Net income
-$14M
-2.04%
Profit margin
0.00%
NaN%

CorMedix Earnings Performance

Earnings per share (EPS)

Company profitability
Beat by 9.91%
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.25
-$0.17
-$0.26
-$0.25
-
Expected
-$0.24
-$0.21
-$0.20
-$0.28
-$0.25
Surprise
3.59%
-18.17%
28.87%
-9.91%
-
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional

Upcoming events

No upcoming events

FAQs

What’s the current market cap for CorMedix stock?

CorMedix (CRMD) has a market cap of $227M as of July 06, 2024.

What is the P/E ratio for CorMedix stock?

The price to earnings (P/E) ratio for CorMedix (CRMD) stock is 0 as of July 06, 2024.

Does CorMedix stock pay dividends?

No, CorMedix (CRMD) stock does not pay dividends to its shareholders as of July 06, 2024.

When is the next CorMedix dividend payment date?

CorMedix (CRMD) stock does not pay dividends to its shareholders.

What is the beta indicator for CorMedix?

CorMedix (CRMD) has a beta rating of 1.79. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.

Buy or sell CorMedix stock

Buy or sell CorMedix stock

Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.
Start investing